Excellthera Inc.
Clinical trials sponsored by Excellthera Inc., explained in plain language.
-
New cord blood treatment shows promise for young cancer patients
Disease control CompletedThis study tested a new method to grow more stem cells from a single cord blood unit before transplant in children and young adults (under 21) with high-risk blood cancers like leukemia. The goal was to help the body recover faster and reduce serious side effects such as infectio…
Phase: PHASE1, PHASE2 • Sponsor: ExCellThera inc. • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Cord blood boost: new drug shows promise in High-Risk leukemia patients
Disease control CompletedThis study tested a new method to make cord blood transplants safer and more effective for 30 people with high-risk leukemia or myelodysplasia. The approach uses a molecule called UM171 to grow more stem cells from a single cord blood unit, helping the body recover faster. Early …
Phase: PHASE2 • Sponsor: ExCellThera inc. • Aim: Disease control
Last updated May 19, 2026 11:59 UTC